MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
A stock logo

A

Agilent Technologies, Inc.

$110.24
-3.24
 (-2.86%)
Exchange:   NYSE
Market Cap:   31.18B
Shares Outstanding:   443.103M
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Healthcare
Industry:  Medical – Diagnostics & Research
   
CEO:  Padraig McDonnell
Full Time Employees:  17900
Address: 
5301 Stevens Creek Boulevard
Santa Clara
CA
95051
US
Website:  https://www.agilent.com
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer’s representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Click to read more…

Revenue Segmentation

MARKETSnap
MARKETSnap

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Login — it's free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

Latest materials on file: 1 2025 (2025/02/26)

Log in to open the full transcript and AI-generated key takeaways.

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue6,833,0006,510,0006,948,000
Gross Profit3,465,0003,535,0003,643,000
EBITDA1,703,0001,874,0001,835,000
Operating Income1,350,0001,488,0001,479,000
Net Income1,240,0001,289,0001,303,000

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets10,763,00011,846,00012,727,000
Total Liabilities4,918,0005,948,0005,986,000
Total Stockholders Equity5,845,0005,898,0006,741,000
Total Debt2,735,0003,574,0003,354,000
Cash and Cash Equivalents1,590,0001,329,0001,789,000

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow1,772,0001,751,0001,303,000
Capital Expenditure-298,000-378,0000
Free Cash Flow1,474,0001,373,0001,303,000
Net Income1,240,0001,289,00036,000
Net Change in Cash537,000-261,000459,000

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2030Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Low)9,164,142.207Full AccessFull AccessFull AccessFull Access
Estimated Revenue (High)9,345,937.576Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Avg)9,255,062.600Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Low)2,489,395.740Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (High)2,538,779.589Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Avg)2,514,093.833Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Low)2,405,599.288Full AccessFull AccessFull AccessFull Access
Estimated Net Income (High)2,467,823.688Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Avg)2,436,720.008Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Low)2,224,215.623Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (High)2,268,338.912Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Avg)2,246,282.779Full AccessFull AccessFull AccessFull Access
Estimated EPS (Avg)8.580Full AccessFull AccessFull AccessFull Access
Estimated EPS (High)8.690Full AccessFull AccessFull AccessFull Access
Estimated EPS (Low)8.470Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated Revenue)9Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated EPS)1Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
6.51B  ?P/S
 (TTM)
: 
4.41
?Net Income
 (TTM)
: 
1.289B  ?P/E
 (TTM)
: 
24.18
?Enterprise Value
 (TTM)
: 
32.776B  ?EV/FCF
 (TTM)
: 
33.01
?Dividend Yield
 (TTM)
: 
0.01  ?Payout Ratio
 (TTM)
: 
0.22
?ROE
 (TTM)
: 
0.2  ?ROIC
 (TTM)
: 
0.12
?Net Debt
 (TTM)
: 
1.896B  ?Debt/Equity
 (TTM)
: 
0.49
?P/B
 (TTM)
: 
4.52  ?Current Ratio
 (TTM)
: 
2.07

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
18.47Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MARKETSnap estimates A intrinsic value between $52.60 – $69.43 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate A Intrinsic Value

Common questions about A valuation

Is Agilent Technologies, Inc. (A) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for Agilent Technologies, Inc. (A) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is A a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether A trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is A’s P/E ratio?

You can see A’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for A?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is A a good long-term investment?

Whether A fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

A

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

-2.86
MARKETSnap

Trading Metrics:

Open: 113.64   Previous Close: 113.48
Day Low: 109.93   Day High: 113.74
Year Low: 96.43   Year High: 160.27
Price Avg 50: 127.46   Price Avg 200: 129.95
Volume: 1.265M   Average Volume: 2.252M

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

Why Is Agilent (A) Down 6.2% Since Last Earnings Report?
27-03-2026 12:32
Why Is Agilent (A) Down 6.2% Since Last Earnings Report?
Aquatic Capital Management LLC Decreases Stake in Agilent Technologies, Inc. $A
16-03-2026 03:25
Aquatic Capital Management LLC Decreases Stake in Agilent Technologies, Inc. $A
Agilent to acquire Biocare Medical in $950 million all-cash deal
09-03-2026 03:09
Agilent to acquire Biocare Medical in $950 million all-cash deal
Agilent to Acquire Biocare Medical, a Global Leader in Clinical and Research Pathology Solutions
09-03-2026 03:00
Agilent to Acquire Biocare Medical, a Global Leader in Clinical and Research Pathology Solutions
Agilent Technologies, Inc. (A) Presents at TD Cowen 46th Annual Health Care Conference Transcript
03-03-2026 13:22
Agilent Technologies, Inc. (A) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Agilent Q1 Earnings Miss Estimates, Revenues Up Y/Y, Shares Fall
26-02-2026 13:55
Agilent Q1 Earnings Miss Estimates, Revenues Up Y/Y, Shares Fall

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap
  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read